Christoph Niederhauser

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


83 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
2023
 
Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015.
Ackermann-Gäumann R., Eyer C., Vock M., Gowland P., Tinguely C., Leib S.L., Bori M., Buser A., Fontana S., Thierbach J. et al., 2023/03. Blood transfusion = Trasfusione del sangue, 21 (2) pp. 100-109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B01A2676532]
2022
Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum.
Niederhauser C., Tinguely C., Stolz M., Vock M., El Dusouqui S.A., Gowland P., 2022/11/23. Viruses, 14 (12) p. 2611. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2EAB3C0FF111]
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde M.T., Niederer R., Wagner N.B., Diem S., Berner F., Hasan Ali O., Hillmann D., Bergamin I., Joerger M., Risch M. et al., 2022/03. Journal of cancer research and clinical oncology, 148 (3) pp. 647-656. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_55D7AEBA3688]
2021
 
Comparison of a New IgG-EIA for the Detection of Anti-Plasmodium Antibodies with Two Currently Used Assays.
Niederhauser C., Tinguely C., Dreier J., Vollmer T., Marti H.P., Nickel B., Klemens J.M., Warnecke J.M., Gowland P., 2021/10. Transfusion medicine and hemotherapy, 48 (5) pp. 265-271. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D4540C48F0DB]
2020
 
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
Voruz S., Gowland P., Eyer C., Widmer N., Abonnenc M., Prudent M., Masouridi-Levrat S., Duchosal M.A., Niederhauser C., 2020/11. Blood transfusion = Trasfusione del sangue, 18 (6) pp. 446-453. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4E6414EA83D]
 
The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial.
Keller P., von Känel R., Hincapié C.A., da Costa B.R., Jüni P., Erlanger T.E., Andina N., Niederhauser C., Lämmle B., Fontana S., 2020/08/26. Scientific reports, 10 (1) p. 14219. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6914949B7D8]
 
Reduced RhD antigen expression caused by two novel RHD variant alleles.
Stettler J., Lejon Crottet S., Still F., Graber J., Niederhauser C., Waldvogel S., Henny C., 2020/04. Transfusion, 60 (4) pp. E7-E8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C48822420834]
2019
 
Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country.
Stolz M., Gowland P., Tinguely C., Niederhauser C., 2019/04. Transfusion medicine and hemotherapy, 46 (2) pp. 104-110. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01E1D441030C]
2018
Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016
Niederhauser Christoph, Widmer Nadja, Hotz Magdalena, Tinguely Caroline, Fontana Stefano, Allemann Gabrielle, Borri Mauro, Infanti Laura, Sarraj Amira, Sigle Jörg et al., 2018/08/30. Eurosurveillance, 23 (35).
[URN][DOI][WoS][Pmid][serval:BIB_C94A6E7A4E44]
Editorial: Transfusion Medicine and Blood.
Prudent M., Tissot J.D., Fontana S., Niederhauser C., 2018. Frontiers in medicine, 5 p. 355. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_48D6D65303DC]
2017
 
West Nile Virus preparedness plan to ensure safe blood components in Switzerland: a risk-based approach
Niederhauser C., Fontana S., Glauser A., Steinemann C., Koller A., 2017/05. ISBT Science Series, 12 (2) pp. 314-321.
[DOI][serval:BIB_1B943FF2EFD1]
Hepatitis E and blood donation safety in selected European countries: a shift to screening?
Domanović D., Tedder R., Blümel J., Zaaijer H., Gallian P., Niederhauser C., Sauleda Oliveras S., O'Riordan J., Boland F., Harritshøj L. et al., 2017/04/20. Euro surveillance, 22 (16). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5EC1716F79D8]
 
Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing : HBV DETECTION IN A MULTI-REGIONAL STUDY
Lelie Nico, Bruhn Roberta, Busch Michael, Vermeulen Marion, Tsoi Wai-Chiu, Kleinman Steven, Niederhauser Christoph, 2017/01. Transfusion, 57 (1) pp. 24-35.
[DOI][WoS][Pmid][serval:BIB_5F56CB54BC0F]
2016
 
Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.
Niederhauser C., Gottschalk J., Tinguely C., 2016/05. Transfusion medicine and hemotherapy, 43 (3) pp. 169-176. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2D35E74B2D67]
 
Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate
Gowland Peter, Fontana Stefano, Stolz Martin, Andina Nicola, Niederhauser Christoph, 2016. Transfusion Medicine and Hemotherapy, 43 (3) pp. 198-202.
[DOI][WoS][Pmid][serval:BIB_C5A491943E2F]
2015
Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests.
Vetter B.N., Orlowski V., Niederhauser C., Walter L., Schüpbach J., 2015/10/29. BMC infectious diseases, 15 p. 468. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53B70E195427]
 
Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R., Lelie N., Busch M., Kleinman S., International NAT Study Group, 2015/06. Transfusion, 55 (6) pp. 1195-1205. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE96A1FB2A0F]
Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.
Schüpbach J., Niederhauser C., Yerly S., Regenass S., Gorgievski M., Aubert V., Ciardo D., Klimkait T., Dollenmaier G., Andreutti C. et al., 2015. Plos One, 10 (7) pp. e0131828. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_43C24B25E1E7]
2014
 
Comparison of a conventional HIV 1/2 line immunoassay with a rapid confirmatory HIV 1/2 assay.
Tinguely C., Schild-Spycher T., Bahador Z., Gowland P., Stolz M., Niederhauser C., 2014. Journal of Virological Methods, 206 pp. 1-4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_33FBB8CA1682]
Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests.
Vetter B.N., Orlowski V., Fransen K., Niederhauser C., Aubert V., Brandenberger M., Ciardo D., Dollenmaier G., Klimkait T., Regenass S. et al., 2014. Plos One, 9 (10) pp. e111552.
[URN][DOI][WoS][Pmid][serval:BIB_1781BD45F2A9]
 
Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
Stolz M., Tinguely C., Fontana S., Niederhauser C., 2014. Transfusion, 54 (11) pp. 2961-2967. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45D7C2D6AFBA]
 
Implementation of a mandatory donor RHD screening in Switzerland.
Crottet S.L., Henny C., Meyer S., Still F., Stolz M., Gottschalk J., Neuenschwander K., Taleghani B.M., Gowland P., Frey B.M. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 169-174. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22032281FE0D]
 
Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.
Gowland P., Gassner C., Hustinx H., Stolz M., Gottschalk J., Tissot J.D., Thierbach J., Maier A., Sigurdardottir S., Still F. et al., 2014. Transfusion and Apheresis Science, 50 (2) pp. 163-168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF8EE2BB43EE]
 
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.
Lieberman L., Devine D.V., Reesink H.W., Panzer S., Wong J., Raison T., Benson S., Pink J., Leitner G.C., Horvath M. et al., 2014. Vox Sanguinis, 107 (3) pp. 276-311. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94FC2DC5B3BA]
2013
 
Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle J.P., Thierbach J., Infanti L., Muriset M., Hunziker G., Chassot K., Niederhauser C., Gowland P., Holbro A., Sunic K. et al., 2013. Vox Sanguinis, 105 (3) pp. 244-252. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_49813DBDAC83]
 
Das schweizerische HIV Testkonzept - eine akutalisierte Version. Concept suisse de test VIH: récapitulatif actualisé.
Schüpbach J., Niederhauser C., Andreutti C., Gorgievski M., Klimkait T., Martinetti G., Regenass S., Yerly S., Aubert V., Brandenberger M. et al., 2013. BAG Bulletin, 47 pp. 851-853.
[serval:BIB_2EA5EF31B11D]
 
Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
Bruhn R., Lelie N., Custer B., Busch M., Kleinman S., International NAT Study Group, 2013. Transfusion, 53 (10 Pt 2) pp. 2399-2412.
[DOI][WoS][Pmid][serval:BIB_CCBF3121C981]
 
Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
Lejon Crottet S., Haer-Wigman L., Gowland P., Fontana S., Niederhauser C., Hustinx H., 2013. Transfusion, 53 (11 Suppl 2) pp. 3000-3008. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_579FB61DFCAD]
 
Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity.
Engler O., Klingstrom J., Aliyev E., Niederhauser C., Fontana S., Strasser M., Portmann J., Signer J., Bankoul S., Frey F. et al., 2013. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18 (50) p. 20660.
[WoS][Pmid][serval:BIB_6B5652341281]
Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.
Schüpbach J., Gebhardt M.D., Scherrer A.U., Bisset L.R., Niederhauser C., Regenass S., Yerly S., Aubert V., Suter F., Pfister S. et al., 2013. Plos One, 8 (8) pp. e71662.
[URN][DOI][WoS][Pmid][serval:BIB_643DBDCA1977]
2012
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.
Schüpbach J., Bisset L.R., Gebhardt M.D., Regenass S., Bürgisser P., Gorgievski M., Klimkait T., Andreutti C., Martinetti G., Niederhauser C. et al., 2012. Bmc Infectious Diseases, 12 p. 88.
[DOI][WoS][Pmid][serval:BIB_775EEDE44A34]
 
Hepatitis B virus in transfusion medicine: still a problem?
Allain J.P., Candotti D., ISBT HBV Safety Collaborative Group, 2012. Biologicals : Journal of the International Association of Biological Standardization, 40 (3) pp. 180-186.
[DOI][WoS][Pmid][serval:BIB_EF8625147718]
 
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
Roth W.K., Busch M.P., Schuller A., Ismay S., Cheng A., Seed C.R., Jungbauer C., Minsk P.M., Sondag-Thull D., Wendel S. et al., 2012. Vox Sanguinis, 102 (1) pp. 82-90. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_705C6962540A]
 
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.
Niederhauser C., Candotti D., Weingand T., Maier A., Tinguely C., Stolz M., Allain J.P., 2012. Journal of Hepatology, 56 (3) pp. 734-737.
[DOI][WoS][Pmid][serval:BIB_08E8EB021560]
2011
 
Genotypisierung von Spendern und Patienten.
Niederhauser C., Crottet Lejon S., 2011. Pipette 5 pp. 16-18.
[serval:BIB_64A1C0A74691]
 
Hepatitis B-Virus: Sicherheit von labilen Blutprodukten.
Niederhauser C., Stolz M., 2011. Pipette 6 pp. 20-22.
[serval:BIB_460874E47FB4]
 
Reducing the risk of hepatitis B virus transfusion-transmitted infection.
Niederhauser C., 2011. Journal of Blood Medicine, 2 pp. 91-102.
[DOI][Pmid][serval:BIB_2BEA8B2579A9]
2010
 
11 Jahre nationales Zentrum für Infektionen durch Blut und Blutprodukte.
Niederhauser C., 2010. BAG Bulletin, 10 pp. 336-344.
[serval:BIB_13CE89D91F64]
 
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region.
Stolz M., Tinguely C., Graziani M., Fontana S., Gowland P., Buser A., Michel M., Canellini G., Züger M., Schumacher P. et al., 2010. Transfusion, 50 (12) pp. 2695-2706. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEB9B0010BBA]
 
Fatal outcome of a hepatitis B virus transfusion-transmitted infection.
Niederhauser C., Weingand T., Candotti D., Maier A., Tinguely C., Wuillemin W.A., Gowland P., Allain J.P., Stolz M., 2010. Vox Sanguinis, 98 (4) pp. 504-507.
[DOI][WoS][Pmid][serval:BIB_635AEB11EBCA]
2009
 
Editorial zum Themenheft «Transfusionsmedizin»
Niederhauser C., 2009. Pipette 4 p. 8.
[serval:BIB_1B3580E39CFB]
 
Molecular basis of the Rh antigen RH48 (JAL).
Hustinx H., Poole J., Bugert P., Gowland P., Still F., Fontana S., Scharberg E.A., Tilley L., Daniels G., Niederhauser C., 2009. Vox Sanguinis, 96 (3) pp. 234-239. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_875EA12B7211]
 
The risk of a second diagnostic window with 4th generation HIV assays: Two cases.
Niederhauser C., Ströhle A., Stolz M., Müller F., Tinguely C., 2009. Journal of Clinical Virology, 45 (4) pp. 367-369.
[DOI][WoS][Pmid][serval:BIB_0F25142D8849]
 
Von der Erbsubstanz über die molekulare Blutgruppendiagnostik zum Routinescreening des Rhesus-D-Gens bei Blutspendern
Niederhauser C., Hustinx H., 2009. Pipette 4 pp. 13-16.
[serval:BIB_242E91E5F0F3]
 
Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 2.
Hustinx H., Fontana S., Gowland P., Niederhauser C., 2009. Transfusion Medicine and Hemotherapy, 36 (3) pp. 228-229. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_670FD10BB129]
2008
Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
Niederhauser C., Mansouri Taleghani B., Graziani M., Stolz M., Tinguely C., Schneider P., 2008/03/08. Swiss medical weekly, 138 (9-10) pp. 134-141. Peer-reviewed.
[WoS][Pmid][serval:BIB_ADBB6AA5B033]
 
Donors with a rare pheno (geno) type.
Reesink H.W., Engelfriet C.P., Schennach H., Gassner C., Wendel S., Fontão-Wendel R., de Brito M.A., Sistonen P., Matilainen J., Peyrard T. et al., 2008. Vox Sanguinis, 95 (3) pp. 236-253. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5C2168A3B930]
 
Occult hepatitis B infection in blood donors.
Reesink H.W., Engelfriet C.P., Henn G., Mayr W.R., Delage G., Bernier F., Krusius T., Assal A., Gallian P., Corbi C. et al., 2008. Vox Sanguinis, 94 (2) pp. 153-166.
[DOI][Pmid][serval:BIB_A857D4803F36]
2007
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
Schüpbach J., Gebhardt M.D., Tomasik Z., Niederhauser C., Yerly S., Bürgisser P., Matter L., Gorgievski M., Dubs R., Schultze D. et al., 2007. PLoS Medicine, 4 (12) pp. e343.
[URN][DOI][WoS][Pmid][serval:BIB_3C3E04EF3399]
2006
 
Das schweizerische HIV-Testkonzept - aktualisierte Übersicht über Technisches Konzept und Laborkonzept.
Andreuti C., Bürgisser P., Dubs R., Steffen I., Gebhardt M., Gorgievski M., Güntert B., Martinetti G., Matter L., Niederhauser C. et al., 2006. BAG Bulletin, 51 (6) pp. 1022-1034.
[serval:BIB_5FABC77F25DD]
 
Jahresbericht 2005: Neugeborenen-Screening in der Schweiz.
Niederhauser C, Torresani T., Steinmann B., 2006. Paediatrica, 17 (4) pp. 45-46.
[serval:BIB_94517FFB0F2D]
 
Transfusion Medicine in Switzerland.
Lévy G., Byland C., Niederhauser C., Schwabe R., Senn M., Mansouri Taleghani B., 2006. Transfusion Medicine and Hemotherapy, 33 (5) pp. 393-400. Peer-reviewed.
[DOI][WoS][serval:BIB_EB48A04AFBEB]
2005
 
Centres de contrôle de qualité en Suisse.
Risch L., Byland C., Niederhauser C., Deom A., Fried R., 2005. Pipette 1 pp. 8-9.
[serval:BIB_7B1A08AA0670]
 
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
Coste J., Reesink H.W., Engelfriet C.P., Laperche S., Brown S., Busch M.P., Cuijpers H.T., Elgin R., Ekermo B., Epstein J.S. et al., 2005. Vox Sanguinis, 88 (4) pp. 289-303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F4A4EF14BB61]
 
Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
Niederhauser C., Schneider P., Fopp M., Ruefer A., Lévy G., 2005. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 10 (2) pp. 14-16.
[Pmid][serval:BIB_D9C42A8DDB36]
 
Jahresbericht 2004: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2005. Paediatrica, 16 (2) pp. 36-37.
[serval:BIB_F63B187D3C37]
 
Sicherheit von Blutprodukten bezüglich viraler Infektionen.
Niederhauser C., 2005. Pipette 3 pp. 6-12.
[serval:BIB_A2903BE981DB]
2004
 
Die medizinischen Qualitätskontrollzentren der Schweiz.
Risch L, Byland C, Niederhauser C, Deom A, Fried R, 2004. Pipette, 3 pp. 24-25.
[serval:BIB_1AAE95DCB0D9]
 
Fachkommission Labor und Diagnostik: Diagnostische Empfehlung. HIV-Testkonzept 2004: Neue Richtlinien zum Screening.
Bürgisser Ph., Dubs W., Erb P., Fierz W., Gebhardt M., Gorgievski M., Güntert B., Matter L., Niederhauser C., Perrin L. et al., 2004. BAG Bulletin, 10 (4) pp. 168-170.
[serval:BIB_A260788567EC]
 
Jahresbericht 2003: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2004. Paediatrica, 15 (2) pp. 35-36.
[serval:BIB_336A296FEBF5]
 
Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus.
Gowland P., Fontana S., Niederhauser C., Taleghani B.M., 2004. Transfusion, 44 (11) pp. 1555-1561. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A7E15D1E37A6]
2003
 
Hepatitis C virus-polymerase chain reaction minipool testing: 3 years in the largest Swiss blood transfusion service.
Stolz M., Gilgen M., Niederhauser C., 2003. Vox Sanguinis, 84 (2) pp. 105-110. Peer-reviewed.
[WoS][Pmid][serval:BIB_7119A53FDB24]
 
Improved sensitivity of the Chlamydia trachomatis Cobas Amplicor assay using an optimized procedure for preparation of specimens.
Niederhauser C., Kaempf L., 2003. European Journal of Clinical Microbiology and Infectious Diseases, 22 (2) pp. 118-121. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_81B403052003]
 
Jahresbericht 2002: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2003. Paediatrica, 14 (2) pp. 46-48.
[serval:BIB_8E38CDD1251E]
The right choice for the job.
Graziani M, Niederhauser C., 2003. Tecan Journal, 1 pp. 10-11.
[serval:BIB_14E5C72E3CF2]
2002
 
Jahresbericht 2001: Neugeborenen-Screening in der Schweiz.
Niederhauser C., Steinmann B., 2002. Paediatrica, 13 (2) pp. 57-59.
[serval:BIB_CB3A6C8EA297]
 
Transfusion-associated Hepatitis A Virus (HAV) Window Period Infection: Documented Re-Infection of a Patient.
Gowland P, Fontana S, Niederhauser C, Mansouri Taleghani B., 2002. Infusion Therapy and Transfusion Medicine, 29 (S1) pp. 22-23.
[serval:BIB_5A79C40340FF]
2001
 
Detection limit, cut-off and specificity of an improved rapid assay for cardiac troponin T.
Baum H., Bertsch T., Bohner J., von Pap K.W., Hoff T., Wilke B., Katz N., Luthe H., Luz H., Nagel D. et al., 2001. Clinical Laboratory, 47 (11-12) pp. 549-554. Peer-reviewed.
[Pmid][serval:BIB_2073F6D8C45E]
 
Jahresbericht 2000: Neugeborenen-Screening in der Schweiz
Niederhauser C., Steinmann B., 2001. Paediatrica, 12 (4) pp. 63-65.
[serval:BIB_564A4455D3C3]
 
Neonatale Bluttransfusion und Hepatitis C im Erwachsenenalter.
Niederhauser C., 2001. Paediatrica, 12 (4) pp. 54-56.
[serval:BIB_04A1C6E88808]
2000
 
Chlamydienscreening: Ist das Nachweisproblem gelöst [Screening of Chlamydia trachomatis: is the diagnostic efficacy good enough?].
Niederhauser C., Honegger C., Kaempf L., 2000. Gynäkologisch-geburtshilfliche Rundschau, 40 (3-4) pp. 134-139.
[DOI][WoS][Pmid][serval:BIB_C451E6005B54]
 
Ist die Diagnose einer konnatalen Zytomegalie Infektion im Nachhinein in der Schweiz möglich ?
Niederhauser C., 2000. Paediatrica, 11 pp. 43-44.
[serval:BIB_665FFA811EFD]
 
Use of the ligase detection reaction-polymerase chain reaction to identify point mutations in extended-spectrum beta-lactamases.
Niederhauser C., Kaempf L., Heinzer I., 2000. European Journal of Clinical Microbiology and Infectious Diseases, 19 (6) pp. 477-480. Peer-reviewed.
[WoS][Pmid][serval:BIB_44498871A3A7]
1996
 
Gentechnologisch veränderte pflanzliche Lebensmittel : Stand der anwendungsorientierten Forschung und potentielle Nachweismöglichkeiten mit molekularbiologischen Methoden [Genetically engineered food plants : Research and detection with DNA-analytical methods]
Niederhauser C., Gilgen M., Meyer R., 1996. Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene, 87 (3) pp. 307-367.
[serval:BIB_C56688FC65A4]
1995
 
Polymerase chain reaction (PCR) for detection of pathogenic microorganisms in bacteriological monitoring of dairy products.
Allmann M., Höfelein C., Köppel E., Lüthy J., Meyer R., Niederhauser C., Wegmüller B., Candrian U., 1995. Research in Microbiology, 146 (1) pp. 85-97. Peer-reviewed.
[WoS][Pmid][serval:BIB_119A8F14BC7D]
1994
 
Direct detection of Listeria monocytogenes using paramagnetic bead DNA extraction and enzymatic DNA amplification.
Niederhauser C., Lüthy J., Candrian U., 1994. Molecular and Cellular Probes, 8 (3) pp. 223-228. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87D431859A89]
 
Random amplification of polymorphic bacterial DNA: evaluation of 11 oligonucleotides and application to food contaminated with Listeria monocytogenes.
Niederhauser C., Höfelein C., Allmann M., Burkhalter P., Lüthy J., Candrian U., 1994. Journal of Applied Bacteriology, 77 (5) pp. 574-582. Peer-reviewed.
[WoS][Pmid][serval:BIB_2BF9AC1F5402]
 
Reliability of PCR decontamination systems.
Niederhauser C., Höfelein C., Wegmüller B., Lüthy J., Candrian U., 1994. Pcr Methods and Applications, 4 (2) pp. 117-123.
[Pmid][serval:BIB_7D0B633C49E8]
1993
 
Comparison of "Gen-Probe" DNA probe and PCR for detection of Listeria monocytogenes in naturally contaminated soft cheese and semi-soft cheese.
Niederhauser C., Höfelein C., Lüthy J., Kaufmann U., Bühler H.P., Candrian U., 1993. Research In Microbiology, 144 (1) pp. 47-54. Peer-reviewed.
[WoS][Pmid][serval:BIB_1F8F7FF48402]
 
Nachweis und Charakterisierung von Listeria monocytogenes in Lebensmitteln und klinischem Material.
Niederhauser C., Candrian U., Höfelein C., Lüthy J., 1993. Lebensmittelchemie, 47 p. 67. Peer-reviewed.
[serval:BIB_4CD536C929AE]
 
Ultra sensitive detection of Listeria monocytogenes in milk by PCR.
Candrian U, Niederhauser C., 1993. Letters in Applied Microbiology, 17 p. 144. Peer-reviewed.
[WoS][serval:BIB_11F46B0F8A08]
1992
 
Use of polymerase chain reaction for detection of Listeria monocytogenes in food.
Niederhauser C., Candrian U., Höfelein C., Jermini M., Bühler H.P., Lüthy J., 1992. Applied and Environmental Microbiology, 58 (5) pp. 1564-1568. Peer-reviewed.
[WoS][Pmid][serval:BIB_D85A3DED3923]
1991
 
Polymerase-Kettenreaktion in der bakteriologischen Lebensmitteldiagnostik am Beispiel von Listeria monocytogenes.
Candrian U., Niederhauser C., Höfelein C., Bühler H.P., Müller U., Lüthy J., 1991. Gebiete der Lebensmittelhygiene, 82 pp. 539-588. Peer-reviewed.
[serval:BIB_A57C6FA46306]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University